Language
English
Chinese
COMPANY
About
History
Management
Benefits
Employee-Employer Relationships
Join Us
|
PRODUCT&SERVICE
Product List
CMO & CDMO
Analytical Development
Co-development on Early-stage Products
|
PLANT
Location
Tainan
Tainan Injection Plant
Inspection History
|
INVESTORS
Financials
Annual Reports
Shareholder Services
Press
|
Corporate Governance
Organization
Board Meeting
Functional Committee
Head of Corporate Governance
Internal Audit
Important Rules
Independence Assessment of CPA
Sustainability Report
Stakeholder Area
|
SLC BIOPHARM
Carbapenem
PRODUCT
Paliperidone Palmitate
Cetrorelix Acetate
Ganirelix Acetate
Plecanatide
Prucalopride Succinate
Brinzolamide
INVESTORS
Financials
Annual Reports
Shareholder Services
Press
Press
2015.09.08
/
Savior is officially listed on TWSE
2015.06.26
/
Savior Lifetec Corporation's Application to be listed was approved by the TPEx (Gretai Securities Market) Board of Directors
2015.06.26
/
Savior Lifetec Co., Ltd. -Chunan site passes Anvisa Brazil Audit
2014.12.29
/
Savior Lifetec Corporation's Injection Plant (IP) in Tainan, Taiwan Passes US FDA cGMP Audit
2014.12.17
/
Savior Lifetec Corporation's Active Pharmaceutical Ingredient (API) Manufacturing Facility in Chunan, Taiwan Passes US FDA cGMP Audit
2014.11.27
/
Savior Lifetec Corporation's Meropenem Active Pharmaceutical Ingredient (API) Manufacturing Facility in Tainan, Taiwan Passes TFDA GMP Audit
2014.11.25
/
Savior Lifetec Corporation Submits Application for Listing in the Gretai Securities Market
2014.10.28
/
Savior Lifetec Corporation's Injection Plant (IP) in Tainan, Taiwan Passes ANVISA GMP Audit
2014.10.03
/
Savior Lifetec Corporation's Active Pharmaceutical Ingredient (API) Manufacturing Facility in Tainan, Taiwan Passes US FDA cGMP Audit
2014.06.10
/
Savior Lifetec Corporation Appoints Dr. M. Sherry Ku New Chairman of the Board; Re-elects its Board of Directors and Supervisors
<
1
/
2
/
3
>